Table 4.

Analysis of the lung cancer data using SPRE: identified main effects and interactions.

Gene name	main effects						interactions
	age	gender	smoke	chemo	stage	gene	age	gender	smoke	chemo	stage
XIST	−1.00	−1.21	−0.56	−0.29	−3.89	2.43
ALB	−1.00	0.60	0.05	−0.28	−3.41	3.57	2.49
APOA2	−1.00	0.47	0.01	−0.36	−3.11	4.02
ANXA10	−1.00	0.32	0.16	−0.49	−3.70	−2.93					−2.99
AHSG	−1.00	0.54	0.46	−0.51	−3.27	2.46	3.14
EIF1AY	−1.00	2.33	2.46	−0.35	−2.34	3.45			2.53
CXCL5	−1.00	0.52	2.25	−0.13	−3.56				3.51
TF	−1.00	0.31	−0.24	−0.62	−3.33						−2.58
AGR2	−1.00	1.30	−0.71	−0.62	−3.09				3.08
IL8	−1.00	0.54	0.83	−0.35	−3.01				2.42
HBG1	−1.00	1.06	−0.07	−0.30	−2.51				−2.91
CXCL5	−1.00	0.66	1.06	−0.35	−3.46				3.30
CALB1	−1.00	0.31	0.23	−0.30	−2.73		−4.09
IGFBP1	−1.00	0.27	−0.11	−0.34	−3.18			−2.60
MGP	−1.00	0.93	1.61	−0.32	−2.65				−2.72
KDM5D	−1.00	−0.42	3.24	−1.00	−3.75				2.87
CALB1	−1.00	0.79	0.44	−0.39	−3.45				3.63		−2.63
SLC6A10P	−1.00	0.65	0.42	−0.21	−2.58		2.60
FAM134B	−1.00	1.14	0.97	−0.86	−4.29				2.57
ZIC1	−1.00	0.85	1.36	−0.42	−2.92				2.95
FOXG1	−1.00	0.35	0.05	−0.46	−3.02						−2.58
CEL	−1.00	0.55	−0.15	0.01	−3.31						−2.87
FABP1	−1.00	0.68	0.47	−0.34	−2.14		2.84
SFRP1	−1.00	0.74	1.71	−1.12	−4.25				5.50
FOSL1	−1.00	0.75	1.41	−0.28	−2.44				2.45